Specificity Analysis of Three Clonal and Five Non-Clonal α1,3-l-Fucosyltransferases with Sulfated, Sialylated, or Fucosylated Synthetic Carbohydrates as Acceptors in Relation to the Assembly of 3‘-Sialyl-6‘-sulfo Lewis x (the L-Selectin Ligand) and Related Complex Structures
Authors:
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 35 (27) , 8925-8933
Abstract
Unique specificities of the cloned α1,3-l-fucosyltransferases (FTs), FT III (Lewis type), FT IV (myeloid type), and FT V (plasma type), and the α1,3-FTs of Colo 205 (colon carcinoma), HL 60 (myeloid), B142 (lymphoid), EKVX (lung carcinoma), and calf mesenteric lymph nodes (CMLN) were discerned with sulfated, sialylated, and/or fucosylated Galβ1,3/4GlcNAcβ-based acceptor moieties. (a) FT V was 1.0-, 20.8-, and 4.6-fold active in forming Lewis x, Lewis y, and 3‘-α-galactosyl Lewis x, respectively. (b) FT III and FT V formed ∼4-fold 3‘-sulfo Lewis x, as compared to 3‘-sialyl Lewis x. (c) FT IV showed great efficiency in forming 3‘-sulfo Lewis x (249%) and Lewis x (345%) in mucin-type branched chains. (d) FT III, FT IV, and FT V formed 19%, 62%, and 47% 6-sulfo Lewis x as compared to Lewis x. (e) 6‘-Sulfo Lewis x and 3‘-sialyl-6‘-sulfo Lewis x (GLYCAM ligand) were not synthesized from their immediate precursors by FT III, FT IV, or FT V. (f) FT III, FT IV, and FT V were 311%, 9%, and 188% active, respectively, with 2‘-fucosyl lactose but were not active with 2‘-fucosyl-6‘-sulfo lactose. (g) FT III and FT V were 7.0- and 0.5-fold active in forming Lewis a as compared to Lewis x, whereas, FT IV was inactive. (h) FT III was -2.0-fold more active in forming 3‘-α-galactosyl Lewis a than Lewis b. (i) FT III synthesized 6-sialyl Lewis a (40% efficiency as compared to Lewis a) from 6-sialyl type 1. (j) FT III did not act on 6‘-sulfo or 6‘-sialyl type 1 but was 106% and 22% active with 3‘-sulfo and 6-sulfo type 1, respectively. (k) The Colo 205 FT activities with type 1 compounds almost paralleled that of FT III except for the low activity (9%) with Galβ1,3(NeuAcα2, 6)GlcNAcβ-O-Bn, but with type 2 considerable differences between Colo 205 FT and FT III were noticed. (l) The α1,3-FTs of CMLN, HL60, B142, and EKVX were 1.2−1.7 times active with Fucα1,2Galβ1,4GlcNAcβ-O-pNP and Galα1,3Galβ1,4GlcNAcβ-O-Bn with respect to Galβ1,4GlcNAcβ-O-Al. (m) Both CMLN and HL60 FTs were 2-fold active with 3-sulfoGalβ1,4GlcNAc in a mucin-type branch structure such as 3-sulfoGalβ1,4GlcNAcβ1,6(Galβ1,3)GalNAcα-O-Bn. (n) The 3‘-sulfoLacNAc/acrylamide copolymer, either as an acceptor or as a competitive inhibitor, had the potential to distinguish myeloid type α1,3-FT from the plasma type.Keywords
This publication has 4 references indexed in Scilit:
- Structural and immunochemical identification of Leb glycolipids in the plasma of a group O Le(a-b-) secretorGlycoconjugate Journal, 1995
- Structure of the O-Glycans in GlyCAM-1, an Endothelial-derived Ligand for L-selectinJournal of Biological Chemistry, 1995
- Expression of distinct fucosylated oligosaccharides and carbohydrate-mediated adhesion efficiency directed by two different alpha-1,3-fucosyltransferases. Comparison of E- and L-selectin-mediated adhesion.Journal of Biological Chemistry, 1994
- The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharideJournal of Cell Biology, 1992